PT  - JOURNAL ARTICLE
ED  - Sica, Domenic A.
TI  - All Patients with Uncontrolled Blood Pressure on Valsartan Monotherapy Benefit from Switch to Combination Therapy
DP  - 2010 Nov 01
TA  - MD Conference Express
PG  - 9--9
VI  - 10
IP  - 5
4099  - http://mdc.sagepub.com/content/10/5/9.1.short
4100  - http://mdc.sagepub.com/content/10/5/9.1.full
AB  - Classifying patients with uncontrolled hypertension by degree of response to valsartan monotherapy has a limited value in predicting which patients will benefit from the addition of hydrochlorothiazide (HCTZ), according to findings from a new study. Despite failing to meet blood pressure (BP) targets with valsartan monotherapy, all patients with stage 2 hypertension experienced dose-dependent improvements in BP control with the addition of HCTZ.